The US healthcare industry has said how it contribute to President Obama’s drive to cut healthcare costs, and help save …
US drugmaker Pfizer has been in emergency talks with the government of Venezuela after being threatened with seizure of a …
Pharmafocus presents a round-up of developments in the contract research sector, including a merger between etrials and Merge, new contracts …
Canadian life sciences company MDS has offloaded part of its pharmaceutical services division to INC Research in a $50 million …
For the European biotech industry, the last few years have seen sustained growth across several fronts – much-needed progress after …
NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …
Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …
Healthcare PR specialist HSDcommunicate has been absorbed into advertising agency Woolley Pau. The resulting health PR agency is now called …
The Department of Health and NHS achieved a surplus of £1.67 billion during the financial year 2007-08, a much greater …
Sandoz, the generics arm of Novartis, is to acquire the generic injectables business of Austrian company EBEWE Pharma.The deal, which …
Sanofi-Aventis has signed a deal with oncology-focused biotech Exelixis to co-develop two new cancer treatments.The alliance will see Sanofi gain …
Italian contract research and manufacturing company Pierrel has signed two separate deals to bolster its capabilities in the clinical research …
Projects ranging from diagnostics to diabetes care and genotyping have been given government funding as part of a new award …
Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
I am sure that every marketer reading Pharmafocus is convinced of the value of their brand. Why then do so …
Pharmafocus presents a round-up of developments in the pharmaceutical manufacturing sector, including new facility updates from Alcon, Lonza, Cell Therapeutics, …
The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …
Respiratory drugs saw the biggest growth in GP prescribing in England in 2008, thanks to new COPD targets.The rapid growth …